Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

Eur Heart J. 2018 Jun 21;39(24):2274-2281. doi: 10.1093/eurheartj/ehx625.
No abstract available

MeSH terms

  • Cardiology
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
  • Europe
  • Glucagon-Like Peptide-1 Receptor / agonists
  • Glycated Hemoglobin / metabolism
  • Glycoside Hydrolase Inhibitors / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Incretins / therapeutic use
  • Metformin / therapeutic use
  • Myocardial Infarction / epidemiology
  • Societies, Medical
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
  • Stroke / epidemiology

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Glucagon-Like Peptide-1 Receptor
  • Glycated Hemoglobin A
  • Glycoside Hydrolase Inhibitors
  • Hypoglycemic Agents
  • Incretins
  • Sodium-Glucose Transporter 2 Inhibitors
  • hemoglobin A1c protein, human
  • Metformin